Educational information, not medical advice — ask your doctor or midwife.
Andiroba (Carapa guianensis) is a towering rainforest tree native to the Amazon Basin, found across Brazil, Peru, Colombia, and the Caribbean. Its large seeds yield a thick, slightly bitter oil that has been a cornerstone of Amazonian indigenous medicine for generations. The oil, bark, and leaves are all used medicinally, with the seed oil being the most researched and commercially available form today.
Andiroba's key active compounds are limonoids — particularly gedunin and andirobin — which work similarly to natural anti-inflammatory agents by interfering with pathways that trigger swelling, pain, and immune overreaction. The oil is rich in oleic and linoleic acids that support skin barrier repair and moisture retention. Its bitter limonoids also have natural insect-deterrent and antiparasitic properties, making it a multifunctional botanical.
Cold-pressed andiroba oil is the most traditional and widely used form — applied directly to skin, joints, or muscles. Oral capsules are available for systemic anti-inflammatory effects. Bark decoctions (teas) are used traditionally for fever and respiratory complaints. Creams and salves blended with andiroba oil are popular in Brazil for arthritis and muscle pain relief.
Indigenous Amazonian peoples — including the Kayapó, Ribeirinho, and other forest communities — have used andiroba oil for centuries to repel insects, treat skin infections, heal wounds, and ease joint pain. It was adopted by Brazilian folk medicine and later attracted scientific interest for its limonoid content. It remains one of the most widely sold traditional botanical oils in Brazil and is gaining international recognition in natural health and cosmetic markets.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.